Meeting
2023 ASCO Annual Meeting
Race and ethnicity reporting by US federal standards in high-impact phase 2/3 oncology clinical trial publications.
Authors
Kekoa A. Taparra
Stanford Cancer Institute, Palo Alto, CA
Kekoa A. Taparra , Ryan Benevente , Jonathan Shih , Megan Y. Gimmen , Paul Tominez , Kāʻeo Kekumano , Eric Pineda , Recinda Sherman , Curtiland Deville , Jeffrey M. Peppercorn , Scarlett L. Gomez , Linda D. Bosserman , Fumiko Chino , Manali I. Patel , Chirag S. Shah
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Care Delivery and Regulatory Policy
Track
Care Delivery and Quality Care
Sub Track
Health and Regulatory Policy
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 1595)
DOI
10.1200/JCO.2023.41.16_suppl.1595
Abstract #
1595
Poster Bd #
189
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Source of funding and enrollment disparity in cancer clinical trials.
First Author: Irbaz Bin Riaz
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Source of funding and enrollment disparities in the inclusion of minorities in colorectal clinical trials: A systematic review and meta-analysis.
First Author: Ahsan Ayaz
Poster
2022 ASCO Quality Care Symposium
Racial and ethnic disparities in the cervical cancer screening cascade in three U.S. health care settings.
First Author: Jennifer C. Spencer
Poster
2022 ASCO Annual Meeting
Do publicly available OncoGenomic databases represent the population? A comparative analysis.
First Author: Danielle Brazel